{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:28:03Z","timestamp":1787167683728,"version":"build-2736575974"},"reference-count":152,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neural Regen Res"],"published-print":{"date-parts":[[2022]]},"DOI":"10.4103\/1673-5374.335140","type":"journal-article","created":{"date-parts":[[2022,2,9]],"date-time":"2022-02-09T20:13:46Z","timestamp":1644437626000},"page":"1919","source":"Crossref","is-referenced-by-count":22,"title":["Recent developments of neuroprotective agents for degenerative retinal disorders"],"prefix":"10.4103","volume":"17","author":[{"given":"Jiahui","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kepeng","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youjian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AndrewD","family":"Dick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1673-5374.335140-1","doi-asserted-by":"crossref","unstructured":"Abu-Amero K, Kondkar AA, Chalam KV (2015) An updated review on the genetics of primary open angle glaucoma. Int J Mol Sci 16:28886-28911.","DOI":"10.3390\/ijms161226135"},{"key":"key-10.4103\/1673-5374.335140-2","doi-asserted-by":"crossref","unstructured":"Ahlqvist E, Storm P, K\u00e4r\u00e4j\u00e4m\u00e4ki A, Martinell M, Dorkhan M, Carlsson A, Vikman P, Prasad RB, Aly DM, Almgren P, Wessman Y, Shaat N, Sp\u00e9gel P, Mulder H, Lindholm E, Melander O, Hansson O, Malmqvist U, Lernmark \u00c5, Lahti K, et al. (2018) Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol 6:361-369.","DOI":"10.1016\/S2213-8587(18)30051-2"},{"key":"key-10.4103\/1673-5374.335140-3","doi-asserted-by":"crossref","unstructured":"Alvaro AR, Rosmaninho-Salgado J, Ambr\u00f3sio AF, Cavadas C (2009) Neuropeptide Y inhibits [Ca2+]i changes in rat retinal neurons through NPY Y1, Y4, and Y5 receptors. J Neurochem 109:1508-1515.","DOI":"10.1111\/j.1471-4159.2009.06079.x"},{"key":"key-10.4103\/1673-5374.335140-4","doi-asserted-by":"crossref","unstructured":"Alvaro AR, Martins J, Costa AC, Fernandes E, Carvalho F, Ambr\u00f3sio AF, Cavadas C (2008) Neuropeptide Y protects retinal neural cells against cell death induced by ecstasy. Neuroscience 152:97-105.","DOI":"10.1016\/j.neuroscience.2007.12.027"},{"key":"key-10.4103\/1673-5374.335140-5","doi-asserted-by":"crossref","unstructured":"Alvaro AR, Rosmaninho-Salgado J, Santiago AR, Martins J, Aveleira C, Santos PF, Pereira T, Gouveia D, Carvalho AL, Grouzmann E, Ambr\u00f3sio AF, Cavadas C (2007) NPY in rat retina is present in neurons, in endothelial cells and also in microglial and M\u00fcller cells. Neurochem Int 50:757-763.","DOI":"10.1016\/j.neuint.2007.01.010"},{"key":"key-10.4103\/1673-5374.335140-6","doi-asserted-by":"crossref","unstructured":"Alves CH, Fernandes R, Santiago AR, Ambr\u00f3sio AF (2020) Microglia contribution to the regulation of the retinal and choroidal vasculature in age-related macular degeneration. Cells 9:1217.","DOI":"10.3390\/cells9051217"},{"key":"key-10.4103\/1673-5374.335140-7","doi-asserted-by":"crossref","unstructured":"Ammar MJ, Hsu J, Chiang A, Ho AC, Regillo CD (2020) Age-related macular degeneration therapy: a review. Curr Opin Ophthalmol 31:215-221.","DOI":"10.1097\/ICU.0000000000000657"},{"key":"key-10.4103\/1673-5374.335140-8","doi-asserted-by":"crossref","unstructured":"Barbosa MC, Grosso RA, Fader CM (2018) Hallmarks of aging: an autophagic perspective. Front Endocrinol (Lausanne) 9:790.","DOI":"10.3389\/fendo.2018.00790"},{"key":"key-10.4103\/1673-5374.335140-9","doi-asserted-by":"crossref","unstructured":"Bian B, Zhao C, He X, Gong Y, Ren C, Ge L, Zeng Y, Li Q, Chen M, Weng C, He J, Fang Y, Xu H, Yin ZQ (2020) Exosomes derived from neural progenitor cells preserve photoreceptors during retinal degeneration by inactivating microglia. J Extracell Vesicles 9:1748931.","DOI":"10.1080\/20013078.2020.1748931"},{"key":"key-10.4103\/1673-5374.335140-10","doi-asserted-by":"crossref","unstructured":"Biasutto L, Chiechi A, Couch R, Liotta LA, Espina V (2013) Retinal pigment epithelium (RPE) exosomes contain signaling phosphoproteins affected by oxidative stress. Exp Cell Res 319:2113-2123.","DOI":"10.1016\/j.yexcr.2013.05.005"},{"key":"key-10.4103\/1673-5374.335140-11","doi-asserted-by":"crossref","unstructured":"Boia R, Ruzafa N, Aires ID, Pereiro X, Ambr\u00f3sio AF, Vecino E, Santiago AR (2020) Neuroprotective strategies for retinal ganglion cell degeneration: current status and challenges Ahead. Int J Mol Sci 21:2262.","DOI":"10.3390\/ijms21072262"},{"key":"key-10.4103\/1673-5374.335140-12","doi-asserted-by":"crossref","unstructured":"Bonds DE, Harrington M, Worrall BB, Bertoni AG, Eaton CB, Hsia J, Robinson J, Clemons TE, Fine LJ, Chew EY (2014) Effect of long-chain \u03c9-3 fatty acids and lutein + zeaxanthin supplements on cardiovascular outcomes: results of the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA Intern Med 174:763-771.","DOI":"10.1001\/jamainternmed.2014.328"},{"key":"key-10.4103\/1673-5374.335140-13","doi-asserted-by":"crossref","unstructured":"Brownlee M (2005) The pathobiology of diabetic complications: a unifying mechanism. Diabetes 54:1615-1625.","DOI":"10.2337\/diabetes.54.6.1615"},{"key":"key-10.4103\/1673-5374.335140-14","doi-asserted-by":"crossref","unstructured":"Cabrera AP, Bhaskaran A, Xu J, Yang X, Scott HA, Mohideen U, Ghosh K (2016) Senescence increases choroidal endothelial stiffness and susceptibility to complement injury: implications for choriocapillaris loss in AMD. Invest Ophthalmol Vis Sci 57:5910-5918.","DOI":"10.1167\/iovs.16-19727"},{"key":"key-10.4103\/1673-5374.335140-15","doi-asserted-by":"crossref","unstructured":"Chan CM, Huang CH, Li HJ, Hsiao CY, Su CC, Lee PL, Hung CF (2015) Protective effects of resveratrol against UVA-induced damage in ARPE19 cells. Int J Mol Sci 16:5789-5802.","DOI":"10.3390\/ijms16035789"},{"key":"key-10.4103\/1673-5374.335140-16","doi-asserted-by":"crossref","unstructured":"Chaum E, Winborn CS, Bhattacharya S (2015) Genomic regulation of senescence and innate immunity signaling in the retinal pigment epithelium. Mamm Genome 26:210-221.","DOI":"10.1007\/s00335-015-9568-9"},{"key":"key-10.4103\/1673-5374.335140-17","doi-asserted-by":"crossref","unstructured":"Chen J, Matias I, Dinh T, Lu T, Venezia S, Nieves A, Woodward DF, Di Marzo V (2005) Finding of endocannabinoids in human eye tissues: implications for glaucoma. Biochem Biophys Res Commun 330:1062-1067.","DOI":"10.1016\/j.bbrc.2005.03.095"},{"key":"key-10.4103\/1673-5374.335140-18","unstructured":"Chen L, Ng T, Fan A, Leung D, Zhang M, Wang N, Zheng Y, Liang X, Chiang S, Tam P, Pang C (2012) Evaluation of NTF4 as a causative gene for primary open-angle glaucoma. Mol Vis 18:1763-1772."},{"key":"key-10.4103\/1673-5374.335140-19","doi-asserted-by":"crossref","unstructured":"Chen M, Liu B, Ma J, Ge J, Wang K (2017) Protective effect of mitochondria targeted peptide MTP 131 against oxidative stress induced apoptosis in RGC 5 cells. Mol Med Rep 15:2179-2185.","DOI":"10.3892\/mmr.2017.6271"},{"key":"key-10.4103\/1673-5374.335140-20","doi-asserted-by":"crossref","unstructured":"Chitranshi N, Dheer Y, Abbasi M, You Y, Graham SL, Gupta V (2018) Glaucoma pathogenesis and neurotrophins: focus on the molecular and genetic basis for therapeutic prospects. Curr Neuropharmacol 16:1018-1035.","DOI":"10.2174\/1570159X16666180419121247"},{"key":"key-10.4103\/1673-5374.335140-21","doi-asserted-by":"crossref","unstructured":"Cobb LJ, Lee C, Xiao J, Yen K, Wong RG, Nakamura HK, Mehta HH, Gao Q, Ashur C, Huffman DM, Wan J, Muzumdar R, Barzilai N, Cohen P (2016a) Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers. Aging 8:796-809.","DOI":"10.18632\/aging.100943"},{"key":"key-10.4103\/1673-5374.335140-22","doi-asserted-by":"crossref","unstructured":"Copland DA, Theodoropoulou S, Liu J, Dick AD (2018) A perspective of AMD through the eyes of immunology. Invest Ophthalmol Vis Sci 59:Amd83-amd92.","DOI":"10.1167\/iovs.18-23893"},{"key":"key-10.4103\/1673-5374.335140-23","doi-asserted-by":"crossref","unstructured":"Cremers FPM, Lee W, Collin RWJ, Allikmets R (2020) Clinical spectrum, genetic complexity and therapeutic approaches for retinal disease caused by ABCA4 mutations. Prog Retin Eye Res 79:100861.","DOI":"10.1016\/j.preteyeres.2020.100861"},{"key":"key-10.4103\/1673-5374.335140-24","doi-asserted-by":"crossref","unstructured":"Crespo-Garcia S et al. (2021) Pathological angiogenesis in retinopathy engages cellular senescence and is amenable to therapeutic elimination via BCL-xL inhibition. Cell Metab 33:818-832.","DOI":"10.1016\/j.cmet.2021.01.011"},{"key":"key-10.4103\/1673-5374.335140-25","doi-asserted-by":"crossref","unstructured":"D\u2019Alessandro A, Cervia D, Catalani E, Gevi F, Zolla L, Casini G (2014) Protective effects of the neuropeptides PACAP, substance P and the somatostatin analogue octreotide in retinal ischemia: a metabolomic analysis. Mol Biosyst 10:1290-1304.","DOI":"10.1039\/c3mb70362b"},{"key":"key-10.4103\/1673-5374.335140-26","doi-asserted-by":"crossref","unstructured":"Damani MR, Zhao L, Fontainhas AM, Amaral J, Fariss RN, Wong WT (2011) Age-related alterations in the dynamic behavior of microglia. Aging Cell 10:263-276.","DOI":"10.1111\/j.1474-9726.2010.00660.x"},{"key":"key-10.4103\/1673-5374.335140-27","doi-asserted-by":"crossref","unstructured":"Datta S, Cano M, Ebrahimi K, Wang L, Handa JT (2017) The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD. Prog Retin Eye Res 60:201-218.","DOI":"10.1016\/j.preteyeres.2017.03.002"},{"key":"key-10.4103\/1673-5374.335140-28","doi-asserted-by":"crossref","unstructured":"de la Lastra CA, Villegas I (2005) Resveratrol as an anti-inflammatory and anti-aging agent: mechanisms and clinical implications. Proc Nutr Soc 49:405-430.","DOI":"10.1002\/mnfr.200500022"},{"key":"key-10.4103\/1673-5374.335140-29","doi-asserted-by":"crossref","unstructured":"DeBosch BJ, Heitmeier MR, Mayer AL, Higgins CB, Crowley JR, Kraft TE, Chi M, Newberry EP, Chen Z, Finck BN, Davidson NO, Yarasheski KE, Hruz PW, Moley KH (2016) Trehalose inhibits solute carrier 2A (SLC2A) proteins to induce autophagy and prevent hepatic steatosis. Sci Signal 9:ra21.","DOI":"10.1126\/scisignal.aac5472"},{"key":"key-10.4103\/1673-5374.335140-30","doi-asserted-by":"crossref","unstructured":"Dekeyster E, Geeraerts E, Buyens T, Van den Haute C, Baekelandt V, De Groef L, Salinas-Navarro M, Moons L (2015) Tackling glaucoma from within the brain: an unfortunate interplay of BDNF and TrkB. PLoS One 10:e0142067.","DOI":"10.1371\/journal.pone.0142067"},{"key":"key-10.4103\/1673-5374.335140-31","doi-asserted-by":"crossref","unstructured":"Ding JD, Johnson LV, Herrmann R, Farsiu S, Smith SG, Groelle M, Mace BE, Sullivan P, Jamison JA, Kelly U, Harrabi O, Bollini SS, Dilley J, Kobayashi D, Kuang B, Li W, Pons J, Lin JC, Bowes Rickman C (2011) Anti-amyloid therapy protects against retinal pigmented epithelium damage and vision loss in a model of age-related macular degeneration. Proc Natl Acad Sci U S A 108:E279-287.","DOI":"10.1073\/pnas.1100901108"},{"key":"key-10.4103\/1673-5374.335140-32","doi-asserted-by":"crossref","unstructured":"Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M (2000) Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Acad Sci U S A 97:12222-12226.","DOI":"10.1073\/pnas.97.22.12222"},{"key":"key-10.4103\/1673-5374.335140-33","doi-asserted-by":"crossref","unstructured":"El-Nimri NW, Moore SM, Zangwill LM, Proudfoot JA, Weinreb RN, Skowronska-Krawczyk D, Baxter SL (2020) Evaluating the neuroprotective impact of senolytic drugs on human vision. Sci Rep 10:21752.","DOI":"10.1038\/s41598-020-78802-4"},{"key":"key-10.4103\/1673-5374.335140-34","doi-asserted-by":"crossref","unstructured":"El-Remessy AB, Khalil IE, Matragoon S, Abou-Mohamed G, Tsai NJ, Roon P, Caldwell RB, Caldwell RW, Green K, Liou GI (2003) Neuroprotective effect of (-)Delta9-tetrahydrocannabinol and cannabidiol in N-methyl-D-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite. Am J Pathol 163:1997-2008.","DOI":"10.1016\/S0002-9440(10)63558-4"},{"key":"key-10.4103\/1673-5374.335140-35","doi-asserted-by":"crossref","unstructured":"El-Remessy AB, Al-Shabrawey M, Khalifa Y, Tsai NT, Caldwell RB, Liou GI (2006) Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes. Am J Pathol 168:235-244.","DOI":"10.2353\/ajpath.2006.050500"},{"key":"key-10.4103\/1673-5374.335140-36","doi-asserted-by":"crossref","unstructured":"Erlich H, Valdes AM, Noble J, Carlson JA, Varney M, Concannon P, Mychaleckyj JC, Todd JA, Bonella P, Fear AL, Lavant E, Louey A, Moonsamy P (2008) HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families. Diabetes 57:1084-1092.","DOI":"10.2337\/db07-1331"},{"key":"key-10.4103\/1673-5374.335140-37","doi-asserted-by":"crossref","unstructured":"Ferreira R, Xapelli S, Santos T, Silva AP, Crist\u00f3v\u00e3o A, Cortes L, Malva JO (2010) Neuropeptide Y modulation of interleukin-1{beta} (IL-1{beta})-induced nitric oxide production in microglia. J Biol Chem 285:41921-41934.","DOI":"10.1074\/jbc.M110.164020"},{"key":"key-10.4103\/1673-5374.335140-38","doi-asserted-by":"crossref","unstructured":"G\u00e1briel R (2013) Neuropeptides and diabetic retinopathy. Br J Clin Pharmacol 75:1189-1201.","DOI":"10.1111\/bcp.12003"},{"key":"key-10.4103\/1673-5374.335140-39","doi-asserted-by":"crossref","unstructured":"Gahlaut N, Suarez S, Uddin MI, Gordon AY, Evans SM, Jayagopal A (2015) Nanoengineering of therapeutics for retinal vascular disease. Eur J Pharm Biopharm 95:323-330.","DOI":"10.1016\/j.ejpb.2015.05.001"},{"key":"key-10.4103\/1673-5374.335140-40","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Layana A, Cabrera-L\u00f3pez F, Garc\u00eda-Arum\u00ed J, Arias-Barquet L, Ruiz-Moreno JM (2017) Early and intermediate age-related macular degeneration: update and clinical review. Clin Interv Aging 12:1579-1587.","DOI":"10.2147\/CIA.S142685"},{"key":"key-10.4103\/1673-5374.335140-41","doi-asserted-by":"crossref","unstructured":"Garway-Heath DF, Crabb DP, Bunce C, Lascaratos G, Amalfitano F, Anand N, Azuara-Blanco A, Bourne RR, Broadway DC, Cunliffe IA, Diamond JP, Fraser SG, Ho TA, Martin KR, McNaught AI, Negi A, Patel K, Russell RA, Shah A, Spry PG, et al. (2015) Latanoprost for open-angle glaucoma (UKGTS): a randomised, multicentre, placebo-controlled trial. Lancet 385:1295-1304.","DOI":"10.1016\/S0140-6736(14)62111-5"},{"key":"key-10.4103\/1673-5374.335140-42","doi-asserted-by":"crossref","unstructured":"Gassel C, Reinehr S, Gomes S, Dick H, Joachim S (2020a) Preservation of optic nerve structure by complement inhibition in experimental glaucoma. Cell Tissue Res 382:293-306.","DOI":"10.1007\/s00441-020-03240-7"},{"key":"key-10.4103\/1673-5374.335140-43","doi-asserted-by":"crossref","unstructured":"Gassel CJ, Reinehr S, Gomes SC, Dick HB, Joachim SC (2020b) Preservation of optic nerve structure by complement inhibition in experimental glaucoma. Cell Tissue Res 382:293-306.","DOI":"10.1007\/s00441-020-03240-7"},{"key":"key-10.4103\/1673-5374.335140-44","doi-asserted-by":"crossref","unstructured":"Golestaneh N, Chu Y, Xiao YY, Stoleru GL, Theos AC (2017) Dysfunctional autophagy in RPE, a contributing factor in age-related macular degeneration. Cell Death Dis 8:e2537.","DOI":"10.1038\/cddis.2016.453"},{"key":"key-10.4103\/1673-5374.335140-45","doi-asserted-by":"crossref","unstructured":"Gurunathan S, Kang MH, Jeyaraj M, Qasim M, Kim JH (2019) Review of the isolation, characterization, biological function, and multifarious therapeutic approaches of Exosomes. Cells 8:307.","DOI":"10.3390\/cells8040307"},{"key":"key-10.4103\/1673-5374.335140-46","doi-asserted-by":"crossref","unstructured":"Han J, Li Y, Liu X, Zhou T, Sun H, Edwards P, Gao H, Yu F, Qiao X (2018) Metformin suppresses retinal angiogenesis and inflammation in vitro and in vivo. PLoS One 13:e0193031.","DOI":"10.1371\/journal.pone.0193031"},{"key":"key-10.4103\/1673-5374.335140-47","doi-asserted-by":"crossref","unstructured":"Hanus J, Anderson C, Wang S (2015) RPE necroptosis in response to oxidative stress and in AMD. Ageing Res Rev 24:286-298.","DOI":"10.1016\/j.arr.2015.09.002"},{"key":"key-10.4103\/1673-5374.335140-48","doi-asserted-by":"crossref","unstructured":"Harder JM, Braine CE, Williams PA, Zhu X, MacNicoll KH, Sousa GL, Buchanan RA, Smith RS, Libby RT, Howell GR, John SWM (2017) Early immune responses are independent of RGC dysfunction in glaucoma with complement component C3 being protective. Proc Natl Acad Sci U S A 114:E3839-e3848.","DOI":"10.1073\/pnas.1608769114"},{"key":"key-10.4103\/1673-5374.335140-49","doi-asserted-by":"crossref","unstructured":"He Y, Leung KW, Ren Y, Pei J, Ge J, Tombran-Tink J (2014) PEDF improves mitochondrial function in RPE cells during oxidative stress. Invest Ophthalmol Vis Sci 55:6742-6755.","DOI":"10.1167\/iovs.14-14696"},{"key":"key-10.4103\/1673-5374.335140-50","doi-asserted-by":"crossref","unstructured":"Heesterbeek T, Lechanteur Y, Lor\u00e9s-Motta L, Schick T, Daha M, Altay L, Liakopoulos S, Smailhodzic D, den Hollander A, Hoyng C, de Jong E, Klevering B (2020a) Complement activation levels are related to disease stage in AMD. Invest Ophthalmol Vis Sci 61:18.","DOI":"10.1167\/iovs.61.3.18"},{"key":"key-10.4103\/1673-5374.335140-51","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Zimbr\u00f3n LF, Zamora-Alvarado R, Ochoa-De la Paz L, Velez-Montoya R, Zenteno E, Gulias-Ca\u00f1izo R, Quiroz-Mercado H, Gonzalez-Salinas R (2018) Age-related macular degeneration: new paradigms for treatment and management of AMD. Oxid Med Cell Longev 2018:8374647.","DOI":"10.1155\/2018\/8374647"},{"key":"key-10.4103\/1673-5374.335140-52","doi-asserted-by":"crossref","unstructured":"Himawan E, Ekstr\u00f6m P, Buzgo M, Gaillard P, Stef\u00e1nsson E, Marigo V, Loftsson T, Paquet-Durand F (2019) Drug delivery to retinal photoreceptors. Drug Discov Today 24:1637-1643.","DOI":"10.1016\/j.drudis.2019.03.004"},{"key":"key-10.4103\/1673-5374.335140-53","doi-asserted-by":"crossref","unstructured":"Ho TC, Yang YC, Cheng HC, Wu AC, Chen SL, Tsao YP (2006) Pigment epithelium-derived factor protects retinal pigment epithelium from oxidant-mediated barrier dysfunction. Biochem Biophys Res Commun 342:372-378.","DOI":"10.1016\/j.bbrc.2006.01.164"},{"key":"key-10.4103\/1673-5374.335140-54","doi-asserted-by":"crossref","unstructured":"Holekamp NM, Bouck N, Volpert O (2002) Pigment epithelium-derived factor is deficient in the vitreous of patients with choroidal neovascularization due to age-related macular degeneration. Am J Ophthalmol 134:220-227.","DOI":"10.1016\/S0002-9394(02)01549-0"},{"key":"key-10.4103\/1673-5374.335140-55","doi-asserted-by":"crossref","unstructured":"Holz FG, Sadda SR, Busbee B, Chew EY, Mitchell P, Tufail A, Brittain C, Ferrara D, Gray S, Honigberg L, Martin J, Tong B, Ehrlich JS, Bressler NM, Investigators CaSS (2018) Efficacy and safety of lampalizumab for geographic atrophy due to age-related macular degeneration: chroma and spectri phase 3 randomized clinical trials. JAMA Ophthalmol 136:666-677.","DOI":"10.1001\/jamaophthalmol.2018.1544"},{"key":"key-10.4103\/1673-5374.335140-56","doi-asserted-by":"crossref","unstructured":"Huang DD, Shi G, Jiang Y, Yao C, Zhu C (2020) A review on the potential of Resveratrol in prevention and therapy of diabetes and diabetic complications. Biomed Pharmacother 125:109767.","DOI":"10.1016\/j.biopha.2019.109767"},{"key":"key-10.4103\/1673-5374.335140-57","doi-asserted-by":"crossref","unstructured":"Hubens W, Beckers H, Gorgels T, Webers C (2021) Increased ratios of complement factors C3a to C3 in aqueous humor and serum mark glaucoma progression. Exp Eye Res 204:108460.","DOI":"10.1016\/j.exer.2021.108460"},{"key":"key-10.4103\/1673-5374.335140-58","doi-asserted-by":"crossref","unstructured":"Jaffe G, Westby K, Csaky K, Mon\u00e9s J, Pearlman J, Patel S, Joondeph B, Randolph J, Masonson H, Rezaei K (2021) C5 inhibitor avacincaptad pegol for geographic atrophy due to age-related macular degeneration: a randomized pivotal phase 2\/3 trial. Ophthalmology 128:576-586.","DOI":"10.1016\/j.ophtha.2020.08.027"},{"key":"key-10.4103\/1673-5374.335140-59","doi-asserted-by":"crossref","unstructured":"Josifovska N, Albert R, Nagymih\u00e1ly R, Lytvynchuk L, Moe MC, Kaarniranta K, Ver\u00e9b ZJ, Petrovski G (2020) Resveratrol as inducer of autophagy, pro-survival, and anti-inflammatory stimuli in cultured human RPE cells. Int J Mol Sci 21:813.","DOI":"10.3390\/ijms21030813"},{"key":"key-10.4103\/1673-5374.335140-60","doi-asserted-by":"crossref","unstructured":"Kaarniranta K, Uusitalo H, Blasiak J, Felszeghy S, Kannan R, Kauppinen A, Salminen A, Sinha D, Ferrington D (2020) Mechanisms of mitochondrial dysfunction and their impact on age-related macular degeneration. Prog Retin Eye Res 79:100858.","DOI":"10.1016\/j.preteyeres.2020.100858"},{"key":"key-10.4103\/1673-5374.335140-61","doi-asserted-by":"crossref","unstructured":"Kassa E, Ciulla TA, Hussain RM, Dugel PU (2019a) Complement inhibition as a therapeutic strategy in retinal disorders. Expert Opin Biol Ther 19:335-342.","DOI":"10.1080\/14712598.2019.1575358"},{"key":"key-10.4103\/1673-5374.335140-62","doi-asserted-by":"crossref","unstructured":"Kassa E, Ciulla T, Hussain R, Dugel P (2019b) Complement inhibition as a therapeutic strategy in retinal disorders. Expert Opin Biol Ther 19:335-342.","DOI":"10.1080\/14712598.2019.1575358"},{"key":"key-10.4103\/1673-5374.335140-63","doi-asserted-by":"crossref","unstructured":"Khandhadia S, Lotery A (2010) Oxidation and age-related macular degeneration: insights from molecular biology. Expert Rev Mol Med 12:e34.","DOI":"10.1017\/S146239941000164X"},{"key":"key-10.4103\/1673-5374.335140-64","doi-asserted-by":"crossref","unstructured":"Khatib TZ, Martin KR (2020) Neuroprotection in glaucoma: towards clinical trials and precision medicine. Curr Eye Res 45:327-338.","DOI":"10.1080\/02713683.2019.1663385"},{"key":"key-10.4103\/1673-5374.335140-65","doi-asserted-by":"crossref","unstructured":"Khawaja AP, Cooke Bailey JN, Wareham NJ, Scott RA, Simcoe M, Igo RP, Song YE, Wojciechowski R, Cheng CY, Khaw PT, Pasquale LR, Haines JL, Foster PJ, Wiggs JL, Hammond CJ, Hysi PG (2018) Genome-wide analyses identify 68 new loci associated with intraocular pressure and improve risk prediction for primary open-angle glaucoma. Nat Genet 50:778-782.","DOI":"10.1038\/s41588-018-0126-8"},{"key":"key-10.4103\/1673-5374.335140-66","doi-asserted-by":"crossref","unstructured":"Kim BJ, Mastellos DC, Li Y, Dunaief JL, Lambris JD (2020) Targeting complement components C3 and C5 for the retina: Key concepts and lingering questions. Prog Retin Eye Res:100936.","DOI":"10.1016\/j.preteyeres.2020.100936"},{"key":"key-10.4103\/1673-5374.335140-67","doi-asserted-by":"crossref","unstructured":"Kim Y, Kim M, Choi M, Lee D, Roh G, Kim H, Kang S, Cho G, Hong E, Choi W (2018) Alpha-lipoic acid reduces retinal cell death in diabetic mice. Biochem Biophys Res Commun 503:1307-1314.","DOI":"10.1016\/j.bbrc.2018.07.041"},{"key":"key-10.4103\/1673-5374.335140-68","doi-asserted-by":"crossref","unstructured":"Klingeborn M, Stamer WD, Bowes Rickman C (2018) Polarized exosome release from the retinal pigmented epithelium. Adv Exp Med Biol 1074:539-544.","DOI":"10.1007\/978-3-319-75402-4_65"},{"key":"key-10.4103\/1673-5374.335140-69","doi-asserted-by":"crossref","unstructured":"Kubota S, Ozawa Y, Kurihara T, Sasaki M, Yuki K, Miyake S, Noda K, Ishida S, Tsubota K (2011) Roles of AMP-activated protein kinase in diabetes-induced retinal inflammation. Invest Ophthalmol Vis Sci 52:9142-9148.","DOI":"10.1167\/iovs.11-8041"},{"key":"key-10.4103\/1673-5374.335140-70","doi-asserted-by":"crossref","unstructured":"Kumar-Singh R (2019) The role of complement membrane attack complex in dry and wet AMD - From hypothesis to clinical trials. Ex Eye Res 184:266-277.","DOI":"10.1016\/j.exer.2019.05.006"},{"key":"key-10.4103\/1673-5374.335140-71","doi-asserted-by":"crossref","unstructured":"Kumar S, Ramakrishnan H, Viswanathan S, Akopian A, Bloomfield SA (2021) Neuroprotection of the inner retina also prevents secondary outer retinal pathology in a mouse model of glaucoma. Invest Ophthalmol Vis Sci 62:35.","DOI":"10.1167\/iovs.62.9.35"},{"key":"key-10.4103\/1673-5374.335140-72","doi-asserted-by":"crossref","unstructured":"Kumari R, Astafurov K, Genis A, Danias J (2015) Differential effects of c1qa ablation on glaucomatous damage in two sexes in DBA\/2NNia mice. PLoS One 10:e0142199.","DOI":"10.1371\/journal.pone.0142199"},{"key":"key-10.4103\/1673-5374.335140-73","doi-asserted-by":"crossref","unstructured":"Lee H, Yoon Y, Lee S (2018) Mechanism of neuroprotection by trehalose: controversy surrounding autophagy induction. Cell Death Dis 9:712.","DOI":"10.1038\/s41419-018-0749-9"},{"key":"key-10.4103\/1673-5374.335140-74","doi-asserted-by":"crossref","unstructured":"Lee KS, Lin S, Copland DA, Dick AD, Liu J (2021) Cellular senescence in the aging retina and developments of senotherapies for age-related macular degeneration. J Neuroinflammation 18:32.","DOI":"10.1186\/s12974-021-02088-0"},{"key":"key-10.4103\/1673-5374.335140-75","doi-asserted-by":"crossref","unstructured":"Lee R, Wong TY, Sabanayagam C (2015) Epidemiology of diabetic retinopathy, diabetic macular edema and related vision loss. Eye (London) 2:17.","DOI":"10.1186\/s40662-015-0026-2"},{"key":"key-10.4103\/1673-5374.335140-76","doi-asserted-by":"crossref","unstructured":"Levkovitch-Verbin H (2015) Retinal ganglion cell apoptotic pathway in glaucoma: Initiating and downstream mechanisms. Prog Brain Res 220:37-57.","DOI":"10.1016\/bs.pbr.2015.05.005"},{"key":"key-10.4103\/1673-5374.335140-77","doi-asserted-by":"crossref","unstructured":"Li X, Leng Y, Jiang Q, Wang Z, Luo P, Zhang C, Chen L, Wang Y, Wang H, Yue X, Shen C, Zhou Y, Shi C, Xie L (2020) Eye Drops of metformin prevents fibrosis after glaucoma filtration surgery in rats activating AMPK\/Nrf2 signaling pathway. Front Pharmacol 11:1038.","DOI":"10.3389\/fphar.2020.01038"},{"key":"key-10.4103\/1673-5374.335140-78","doi-asserted-by":"crossref","unstructured":"Liou GI, Auchampach JA, Hillard CJ, Zhu G, Yousufzai B, Mian S, Khan S, Khalifa Y (2008) Mediation of cannabidiol anti-inflammation in the retina by equilibrative nucleoside transporter and A2A adenosine receptor. Invest Ophthalmol Vis Sci 49:5526-5531.","DOI":"10.1167\/iovs.08-2196"},{"key":"key-10.4103\/1673-5374.335140-79","doi-asserted-by":"crossref","unstructured":"Liton PB, Challa P, Stinnett S, Luna C, Epstein DL, Gonzalez P (2005) Cellular senescence in the glaucomatous outflow pathway. Exp Gerontol 40:745-748.","DOI":"10.1016\/j.exger.2005.06.005"},{"key":"key-10.4103\/1673-5374.335140-80","doi-asserted-by":"crossref","unstructured":"Liu C, Cao L, Yang S, Xu L, Liu P, Wang F, Xu D (2015) Subretinal injection of amyloid-\u03b2 peptide accelerates RPE cell senescence and retinal degeneration. Int J Mol Med 35:169-176.","DOI":"10.3892\/ijmm.2014.1993"},{"key":"key-10.4103\/1673-5374.335140-81","doi-asserted-by":"crossref","unstructured":"Liu H, Anders F, Funke S, Mercieca K, Grus F, Prokosch V (2020) Proteome alterations in aqueous humour of primary open angle glaucoma patients. Int J Ophthalmol 13:176-179.","DOI":"10.18240\/ijo.2020.01.24"},{"key":"key-10.4103\/1673-5374.335140-82","doi-asserted-by":"crossref","unstructured":"Liu J, Copland DA, Theodoropoulou S, Chiu HA, Barba MD, Mak KW, Mack M, Nicholson LB, Dick AD (2016) Impairing autophagy in retinal pigment epithelium leads to inflammasome activation and enhanced macrophage-mediated angiogenesis. Sci Rep 6:20639.","DOI":"10.1038\/srep20639"},{"key":"key-10.4103\/1673-5374.335140-83","doi-asserted-by":"crossref","unstructured":"Liu K, Ma L, Lai T, Brelen M, Tam P, Tham C, Pang C, Chen L (2019) C5Evaluation of the association of with neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. Eye (London) 6:34.","DOI":"10.1186\/s40662-019-0161-2"},{"key":"key-10.4103\/1673-5374.335140-84","doi-asserted-by":"crossref","unstructured":"Lorenz K, Scheller Y, Bell K, Grus F, Ponto KA, Bock F, Cursiefen C, Flach J, Gehring M, Peto T, Silva R, Tal Y, Pfeiffer N (2017) A prospective, randomised, placebo-controlled, double-masked, three-armed, multicentre phase II\/III trial for the Study of a Topical Treatment of Ischaemic Central Retinal Vein Occlusion to Prevent Neovascular Glaucoma - the STRONG study: study protocol for a randomised controlled trial. Trials 18:128.","DOI":"10.1186\/s13063-017-1861-3"},{"key":"key-10.4103\/1673-5374.335140-85","doi-asserted-by":"crossref","unstructured":"Lotfi P, Tse DY, Di Ronza A, Seymour ML, Martano G, Cooper JD, Pereira FA, Passafaro M, Wu SM, Sardiello M (2018) Trehalose reduces retinal degeneration, neuroinflammation and storage burden caused by a lysosomal hydrolase deficiency. Autophagy 14:1419-1434.","DOI":"10.1080\/15548627.2018.1474313"},{"key":"key-10.4103\/1673-5374.335140-86","doi-asserted-by":"crossref","unstructured":"Loukovaara S, Nurkkala H, Tamene F, Gucciardo E, Liu X, Repo P, Lehti K, Varjosalo M (2015) Quantitative proteomics analysis of vitreous humor from diabetic retinopathy patients. J Proteome Res 14:5131-5143.","DOI":"10.1021\/acs.jproteome.5b00900"},{"key":"key-10.4103\/1673-5374.335140-87","doi-asserted-by":"crossref","unstructured":"Luo H, Zhuang J, Hu P, Ye W, Chen S, Pang Y, Li N, Deng C, Zhang X (2018) Resveratrol delays retinal ganglion cell loss and attenuates gliosis-related inflammation from ischemia-reperfusion injury. Invest Ophthalmol Vis Sci 59:3879-3888.","DOI":"10.1167\/iovs.18-23806"},{"key":"key-10.4103\/1673-5374.335140-88","doi-asserted-by":"crossref","unstructured":"Lusthaus J, Goldberg I (2019) Current management of glaucoma. Med J Aust 210:180-187.","DOI":"10.5694\/mja2.50020"},{"key":"key-10.4103\/1673-5374.335140-89","doi-asserted-by":"crossref","unstructured":"Ma N, Yang X, Qi C, Yu Q, Zhu C, Ren H (2021) Farrerol enhances Nrf2-mediated defense mechanisms against hydrogen peroxide-induced oxidative damage in human retinal pigment epithelial cells by activating akt and MAPK. Oxid Med Cell Longev 2021:8847844.","DOI":"10.1155\/2021\/8847844"},{"key":"key-10.4103\/1673-5374.335140-90","doi-asserted-by":"crossref","unstructured":"Ma ZW, Liu DX (2018) Humanin decreases mitochondrial membrane permeability by inhibiting the membrane association and oligomerization of Bax and Bid proteins. Acta Pharmacol Sin 39:1012-1021.","DOI":"10.1038\/aps.2017.169"},{"key":"key-10.4103\/1673-5374.335140-91","doi-asserted-by":"crossref","unstructured":"Madeira MH, Boia R, Santos PF, Ambr\u00f3sio AF, Santiago AR (2015) Contribution of microglia-mediated neuroinflammation to retinal degenerative diseases. Mediators Inflamm 2015:673090.","DOI":"10.1155\/2015\/673090"},{"key":"key-10.4103\/1673-5374.335140-92","doi-asserted-by":"crossref","unstructured":"Matias I, Wang JW, Moriello AS, Nieves A, Woodward DF, Di Marzo V (2006) Changes in endocannabinoid and palmitoylethanolamide levels in eye tissues of patients with diabetic retinopathy and age-related macular degeneration. Prostaglandins Leukot Essent Fatty Acids 75:413-418.","DOI":"10.1016\/j.plefa.2006.08.002"},{"key":"key-10.4103\/1673-5374.335140-93","doi-asserted-by":"crossref","unstructured":"Mayer AL, Higgins CB, Heitmeier MR, Kraft TE, Qian X, Crowley JR, Hyrc KL, Beatty WL, Yarasheski KE, Hruz PW, DeBosch BJ (2016) SLC2A8 (GLUT8) is a mammalian trehalose transporter required for trehalose-induced autophagy. Sci Rep 6:38586.","DOI":"10.1038\/srep38586"},{"key":"key-10.4103\/1673-5374.335140-94","doi-asserted-by":"crossref","unstructured":"Menon M, Mohammadi S, Davila-Velderrain J, Goods BA, Cadwell TD, Xing Y, Stemmer-Rachamimov A, Shalek AK, Love JC, Kellis M, Hafler BP (2019) Single-cell transcriptomic atlas of the human retina identifies cell types associated with age-related macular degeneration. Nat Commun 10:4902.","DOI":"10.1038\/s41467-019-12780-8"},{"key":"key-10.4103\/1673-5374.335140-95","doi-asserted-by":"crossref","unstructured":"Menzies FM, Fleming A, Caricasole A, Bento CF, Andrews SP, Ashkenazi A, F\u00fcllgrabe J, Jackson A, Jimenez Sanchez M, Karabiyik C, Licitra F, Lopez Ramirez A, Pavel M, Puri C, Renna M, Ricketts T, Schlotawa L, Vicinanza M, Won H, Zhu Y, et al. (2017) Autophagy and neurodegeneration: pathogenic mechanisms and therapeutic opportunities. Neuron 93:1015-1034.","DOI":"10.1016\/j.neuron.2017.01.022"},{"key":"key-10.4103\/1673-5374.335140-96","doi-asserted-by":"crossref","unstructured":"Michelis G, German OL, Villasmil R, Soto T, Rotstein NP, Politi L, Becerra SP (2021) Pigment epithelium-derived factor (PEDF) and derived peptides promote survival and differentiation of photoreceptors and induce neurite-outgrowth in amacrine neurons. J Neurochem doi: 10.1111\/jnc.15454.","DOI":"10.1101\/2021.01.01.425044"},{"key":"key-10.4103\/1673-5374.335140-97","doi-asserted-by":"crossref","unstructured":"Mikitsh JL, Chacko AM (2014) Pathways for small molecule delivery to the central nervous system across the blood-brain barrier. Perspect Medicin Chem 6:11-24.","DOI":"10.4137\/PMC.S13384"},{"key":"key-10.4103\/1673-5374.335140-98","doi-asserted-by":"crossref","unstructured":"Minasyan L, Sreekumar PG, Hinton DR, Kannan R (2017) Protective mechanisms of the mitochondrial-derived peptide humanin in oxidative and endoplasmic reticulum stress in RPE cells. Oxid Med Cell Longev 2017:1675230.","DOI":"10.1155\/2017\/1675230"},{"key":"key-10.4103\/1673-5374.335140-99","doi-asserted-by":"crossref","unstructured":"Nashine S, Cohen P, Nesburn AB, Kuppermann BD, Kenney MC (2018) Characterizing the protective effects of SHLP2, a mitochondrial-derived peptide, in macular degeneration. Sci Rep 8:15175.","DOI":"10.1038\/s41598-018-33290-5"},{"key":"key-10.4103\/1673-5374.335140-100","doi-asserted-by":"crossref","unstructured":"Nojima H, Freeman CM, Schuster RM, Japtok L, Kleuser B, Edwards MJ, Gulbins E, Lentsch AB (2016) Hepatocyte exosomes mediate liver repair and regeneration via sphingosine-1-phosphate. J Hepatol 64:60-68.","DOI":"10.1016\/j.jhep.2015.07.030"},{"key":"key-10.4103\/1673-5374.335140-101","doi-asserted-by":"crossref","unstructured":"Noristani R, Kuehn S, Stute G, Reinehr S, Stellbogen M, Dick HB, Joachim SC (2016) Retinal and optic nerve damage is associated with early glial responses in an experimental autoimmune glaucoma model. J Mol Neurosci 58:470-482.","DOI":"10.1007\/s12031-015-0707-2"},{"key":"key-10.4103\/1673-5374.335140-102","doi-asserted-by":"crossref","unstructured":"Nozaki M, Raisler BJ, Sakurai E, Sarma JV, Barnum SR, Lambris JD, Chen Y, Zhang K, Ambati BK, Baffi JZ, Ambati J (2006) Drusen complement components C3a and C5a promote choroidal neovascularization. Proc Natl Acad Sci U S A 103:2328-2333.","DOI":"10.1073\/pnas.0408835103"},{"key":"key-10.4103\/1673-5374.335140-103","doi-asserted-by":"crossref","unstructured":"Ogata N, Nishikawa M, Nishimura T, Mitsuma Y, Matsumura M (2002) Unbalanced vitreous levels of pigment epithelium-derived factor and vascular endothelial growth factor in diabetic retinopathy. Am J Ophthalmol 134:348-353.","DOI":"10.1016\/S0002-9394(02)01568-4"},{"key":"key-10.4103\/1673-5374.335140-104","doi-asserted-by":"crossref","unstructured":"Ortega A, Martinez-Arroyo O, Forner MJ, Cortes R (2020) Exosomes as Drug delivery systems: endogenous nanovehicles for treatment of systemic lupus erythematosus. Pharmaceutics 13:3.","DOI":"10.3390\/pharmaceutics13010003"},{"key":"key-10.4103\/1673-5374.335140-105","doi-asserted-by":"crossref","unstructured":"Ou K, Mertsch S, Theodoropoulou S, Wu J, Liu J, Copland DA, Schrader S, Liu L, Dick AD (2019) Restoring retinal neurovascular health via substance P. Exp Cell Res 380:115-123.","DOI":"10.1016\/j.yexcr.2019.04.008"},{"key":"key-10.4103\/1673-5374.335140-106","doi-asserted-by":"crossref","unstructured":"Ou K, Copland DA, Theodoropoulou S, Mertsch S, Li Y, Liu J, Schrader S, Liu L, Dick AD (2020) Treatment of diabetic retinopathy through neuropeptide Y-mediated enhancement of neurovascular microenvironment. J Cell Mol Med 24:3958-3970.","DOI":"10.1111\/jcmm.15016"},{"key":"key-10.4103\/1673-5374.335140-107","doi-asserted-by":"crossref","unstructured":"Palmieri M, Pal R, Nelvagal HR, Lotfi P, Stinnett GR, Seymour ML, Chaudhury A, Bajaj L, Bondar VV, Bremner L, Saleem U, Tse DY, Sanagasetti D, Wu SM, Neilson JR, Pereira FA, Pautler RG, Rodney GG, Cooper JD, Sardiello M (2017) mTORC1-independent TFEB activation via Akt inhibition promotes cellular clearance in neurodegenerative storage diseases. Nat Commun 8:14338.","DOI":"10.1038\/ncomms14338"},{"key":"key-10.4103\/1673-5374.335140-108","doi-asserted-by":"crossref","unstructured":"Park DH, Connor KM, Lambris JD (2019) The challenges and promise of complement therapeutics for ocular diseases. Front Immunol 10:1007.","DOI":"10.3389\/fimmu.2019.01007"},{"key":"key-10.4103\/1673-5374.335140-109","doi-asserted-by":"crossref","unstructured":"Patrick DM, Leone AK, Shellenberger JJ, Dudowicz KA, King JM (2006) Proinflammatory cytokines tumor necrosis factor-alpha and interferon-gamma modulate epithelial barrier function in Madin-Darby canine kidney cells through mitogen activated protein kinase signaling. BMC Physiol 6:2.","DOI":"10.1186\/1472-6793-6-2"},{"key":"key-10.4103\/1673-5374.335140-110","doi-asserted-by":"crossref","unstructured":"Peng J, Xiong S, Ding L, Peng J, Xia X (2019) Diabetic retinopathy: Focus on NADPH oxidase and its potential as therapeutic target. Eur J Pharmacol 853:381-387.","DOI":"10.1016\/j.ejphar.2019.04.038"},{"key":"key-10.4103\/1673-5374.335140-111","unstructured":"Qu S, Zhang C, Liu D, Wu J, Tian H, Lu L, Xu G, Liu F, Zhang J (2020) Metformin protects ARPE-19 cells from glyoxal-induced oxidative stress. Oxid Med Cell Longev 2020:1740943."},{"key":"key-10.4103\/1673-5374.335140-112","doi-asserted-by":"crossref","unstructured":"Rapino C, Tortolani D, Scipioni L, Maccarrone M (2018) Neuroprotection by (endo) cannabinoids in glaucoma and retinal neurodegenerative diseases. Curr Neuropharmacol 16:959-970.","DOI":"10.2174\/1570159X15666170724104305"},{"key":"key-10.4103\/1673-5374.335140-113","doi-asserted-by":"crossref","unstructured":"Rochette L, Ghibu S, Muresan A, Vergely C (2015) Alpha-lipoic acid: molecular mechanisms and therapeutic potential in diabetes. Can J Physiol Pharmacol 93:1021-1027.","DOI":"10.1139\/cjpp-2014-0353"},{"key":"key-10.4103\/1673-5374.335140-114","doi-asserted-by":"crossref","unstructured":"Rother RP, Rollins SA, Mojcik CF, Brodsky RA, Bell L (2007) Discovery and development of the complement inhibitor eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria. Nat Biotechnol 25:1256-1264.","DOI":"10.1038\/nbt1344"},{"key":"key-10.4103\/1673-5374.335140-115","doi-asserted-by":"crossref","unstructured":"Ruan Y, Jiang S, Musayeva A, Gericke A (2020) Oxidative stress and vascular dysfunction in the retina: therapeutic strategies. Antioxidants (Basel) 9:761.","DOI":"10.3390\/antiox9080761"},{"key":"key-10.4103\/1673-5374.335140-116","doi-asserted-by":"crossref","unstructured":"Sacks D, Baxter B, Campbell BCV, Carpenter JS, Cognard C, Dippel D, Eesa M, Fischer U, Hausegger K, Hirsch JA, Shazam Hussain M, Jansen O, Jayaraman MV, Khalessi AA, Kluck BW, Lavine S, Meyers PM, Ramee S, R\u00fcfenacht DA, Schirmer CM, et al. (2018) Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke. Int J Stroke 13:612-632.","DOI":"10.1016\/j.jvir.2017.11.026"},{"key":"key-10.4103\/1673-5374.335140-117","doi-asserted-by":"crossref","unstructured":"Sahajpal N, Goel R, Chaubey A, Aurora R, Jain S (2019) Pathological perturbations in diabetic retinopathy: hyperglycemia, AGEs, oxidative stress and inflammatory pathways. Curr Protein Pept Sci 20:92-110.","DOI":"10.2174\/1389203719666180928123449"},{"key":"key-10.4103\/1673-5374.335140-118","doi-asserted-by":"crossref","unstructured":"Santos-Carvalho A, Elvas F, Alvaro AR, Ambr\u00f3sio AF, Cavadas C (2013) Neuropeptide Y receptors activation protects rat retinal neural cells against necrotic and apoptotic cell death induced by glutamate. Cell Death Dis 4:e636.","DOI":"10.1038\/cddis.2013.160"},{"key":"key-10.4103\/1673-5374.335140-119","doi-asserted-by":"crossref","unstructured":"Shahulhameed S, Vishwakarma S, Chhablani J, Tyagi M, Pappuru R, Jakati S, Chakrabarti S, Kaur I (2020) A systematic investigation on complement pathway activation in diabetic retinopathy. Front Immunol 11:154.","DOI":"10.3389\/fimmu.2020.00154"},{"key":"key-10.4103\/1673-5374.335140-120","doi-asserted-by":"crossref","unstructured":"Silva KC, Rosales MA, Biswas SK, Lopes de Faria JB, Lopes de Faria JM (2009) Diabetic retinal neurodegeneration is associated with mitochondrial oxidative stress and is improved by an angiotensin receptor blocker in a model combining hypertension and diabetes. Diabetes 58:1382-1390.","DOI":"10.2337\/db09-0166"},{"key":"key-10.4103\/1673-5374.335140-121","doi-asserted-by":"crossref","unstructured":"Sim\u00f3-Servat O, Hern\u00e1ndez C, Sim\u00f3 R (2018) Somatostatin and diabetic retinopathy: an evolving story. Endocrine 60:1-3.","DOI":"10.1007\/s12020-018-1561-0"},{"key":"key-10.4103\/1673-5374.335140-122","doi-asserted-by":"crossref","unstructured":"Sim\u00f3 R, Lecube A, Sararols L, Garc\u00eda-Arum\u00ed J, Segura RM, Casamitjana R, Hern\u00e1ndez C (2002) Deficit of somatostatin-like immunoreactivity in the vitreous fluid of diabetic patients: possible role in the development of proliferative diabetic retinopathy. Diabetes Care 25:2282-2286.","DOI":"10.2337\/diacare.25.12.2282"},{"key":"key-10.4103\/1673-5374.335140-123","doi-asserted-by":"crossref","unstructured":"Solomon SD, Chew E, Duh EJ, Sobrin L, Sun JK, VanderBeek BL, Wykoff CC, Gardner TW (2017) Diabetic retinopathy: a position statement by the american diabetes association. Diabetes Care 40:412-418.","DOI":"10.2337\/dc16-2641"},{"key":"key-10.4103\/1673-5374.335140-124","unstructured":"Song D, Sulewski ME, Wang C, Song J, Bhuyan R, Sterling J, Clark E, Song WC, Dunaief JL (2017) Complement C5a receptor knockout has diminished light-induced microglia\/macrophage retinal migration. Mol Vis 23:210-218."},{"key":"key-10.4103\/1673-5374.335140-125","doi-asserted-by":"crossref","unstructured":"Sreekumar PG, Hinton DR, Kannan R (2020) The emerging role of senescence in ocular disease. Oxid Med Cell Longev 2020:2583601.","DOI":"10.1155\/2020\/2583601"},{"key":"key-10.4103\/1673-5374.335140-126","doi-asserted-by":"crossref","unstructured":"Sreekumar PG, Ishikawa K, Spee C, Mehta HH, Wan J, Yen K, Cohen P, Kannan R, Hinton DR (2016) The Mitochondrial-derived peptide humanin protects rpe cells from oxidative stress, senescence, and mitochondrial dysfunction. Invest Ophthalmol Vis Sci 57:1238-1253.","DOI":"10.1167\/iovs.15-17053"},{"key":"key-10.4103\/1673-5374.335140-127","doi-asserted-by":"crossref","unstructured":"Stitt A (2010) AGEs and diabetic retinopathy. Invest Ophthalmol Vis Sci 51:4867-4874.","DOI":"10.1167\/iovs.10-5881"},{"key":"key-10.4103\/1673-5374.335140-128","unstructured":"Takano K, Kojima T, Sawada N, Himi T (2014) Role of tight junctions in signal transduction: an update. EXCLI J 13:1145-1162."},{"key":"key-10.4103\/1673-5374.335140-129","doi-asserted-by":"crossref","unstructured":"Thomas CC, Philipson LH (2015) Update on diabetes classification. Med Clin North Am 99:1-16.","DOI":"10.1016\/j.mcna.2014.08.015"},{"key":"key-10.4103\/1673-5374.335140-130","doi-asserted-by":"crossref","unstructured":"Toomey C, Johnson L, Bowes Rickman C (2018) Complement factor H in AMD: Bridging genetic associations and pathobiology. Prog Retin Eye Res 62:38-57.","DOI":"10.1016\/j.preteyeres.2017.09.001"},{"key":"key-10.4103\/1673-5374.335140-131","unstructured":"Troger J, Neyer S, Heufler C, Huemer H, Schmid E, Griesser U, Kralinger M, Kremser B, Baldissera I, Kieselbach G (2001) Substance P and vasoactive intestinal polypeptide in the streptozotocin-induced diabetic rat retina. Invest Ophthalmol Vis Sci 42:1045-1050."},{"key":"key-10.4103\/1673-5374.335140-132","doi-asserted-by":"crossref","unstructured":"Uckermann O, Wolf A, Kutzera F, Kalisch F, Beck-Sickinger AG, Wiedemann P, Reichenbach A, Bringmann A (2006) Glutamate release by neurons evokes a purinergic inhibitory mechanism of osmotic glial cell swelling in the rat retina: activation by neuropeptide Y. J Neurosci Res 83:538-550.","DOI":"10.1002\/jnr.20760"},{"key":"key-10.4103\/1673-5374.335140-133","doi-asserted-by":"crossref","unstructured":"Upadhyay RK (2014) Drug delivery systems, CNS protection, and the blood brain barrier. Biomed Res Int 2014:869269.","DOI":"10.1155\/2014\/869269"},{"key":"key-10.4103\/1673-5374.335140-134","doi-asserted-by":"crossref","unstructured":"Voigt AP, Mulfaul K, Mullin NK, Flamme-Wiese MJ, Giacalone JC, Stone EM, Tucker BA, Scheetz TE, Mullins RF (2019) Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration. Proc Natl Acad Sci U S A 116:24100-24107.","DOI":"10.1073\/pnas.1914143116"},{"key":"key-10.4103\/1673-5374.335140-135","doi-asserted-by":"crossref","unstructured":"Wang MTM, Danesh-Meyer HV (2021) Cannabinoids and the eye. Surv Ophthalmol 66:327-345.","DOI":"10.1016\/j.survophthal.2020.07.002"},{"key":"key-10.4103\/1673-5374.335140-136","doi-asserted-by":"crossref","unstructured":"Wang S, Wang X, Cheng Y, Ouyang W, Sang X, Liu J, Su Y, Liu Y, Li C, Yang L, Jin L, Wang Z (2019) Autophagy dysfunction, cellular senescence, and abnormal immune-inflammatory responses in AMD: from mechanisms to therapeutic potential. Oxid Med Cell Longev 2019:3632169.","DOI":"10.1155\/2019\/3632169"},{"key":"key-10.4103\/1673-5374.335140-137","doi-asserted-by":"crossref","unstructured":"Wang W, Lo ACY (2018) Diabetic retinopathy: pathophysiology and treatments. Int J Mol Sci 19:1816.","DOI":"10.3390\/ijms19061816"},{"key":"key-10.4103\/1673-5374.335140-138","doi-asserted-by":"crossref","unstructured":"Wang Y, Zhang Q, Yang G, Wei Y, Li M, Du E, Li H, Song Z, Tao Y (2021) RPE-derived exosomes rescue the photoreceptors during retina degeneration: an intraocular approach to deliver exosomes into the subretinal space. Drug Deliv 28:218-228.","DOI":"10.1080\/10717544.2020.1870584"},{"key":"key-10.4103\/1673-5374.335140-139","doi-asserted-by":"crossref","unstructured":"Weinreb RN, Aung T, Medeiros FA (2014) The pathophysiology and treatment of glaucoma: a review. JAMA 311:1901-1911.","DOI":"10.1001\/jama.2014.3192"},{"key":"key-10.4103\/1673-5374.335140-140","doi-asserted-by":"crossref","unstructured":"Williams PA, Tribble JR, Pepper KW, Cross SD, Morgan BP, Morgan JE, John SW, Howell GR (2016) Inhibition of the classical pathway of the complement cascade prevents early dendritic and synaptic degeneration in glaucoma. Mol Neurodegener 11:26.","DOI":"10.1186\/s13024-016-0091-6"},{"key":"key-10.4103\/1673-5374.335140-141","doi-asserted-by":"crossref","unstructured":"Wong WL, Su X, Li X, Cheung CM, Klein R, Cheng CY, Wong TY (2014) Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2:106-116.","DOI":"10.1016\/S2214-109X(13)70145-1"},{"key":"key-10.4103\/1673-5374.335140-142","doi-asserted-by":"crossref","unstructured":"Wubben TJ, Zacks DN, Besirli CG (2019) Retinal neuroprotection: current strategies and future directions. Curr Opin Ophthalmol 30:199-205.","DOI":"10.1097\/ICU.0000000000000558"},{"key":"key-10.4103\/1673-5374.335140-143","doi-asserted-by":"crossref","unstructured":"Xu H, Chen M (2016) Targeting the complement system for the management of retinal inflammatory and degenerative diseases. Eur J Pharmacol 787:94-104.","DOI":"10.1016\/j.ejphar.2016.03.001"},{"key":"key-10.4103\/1673-5374.335140-144","doi-asserted-by":"crossref","unstructured":"Yang JH, Guo Z, Zhang T, Meng XX, Xie LS (2013) Restoration of endogenous substance P is associated with inhibition of apoptosis of retinal cells in diabetic rats. Regul Pept 187:12-16.","DOI":"10.1016\/j.regpep.2013.09.001"},{"key":"key-10.4103\/1673-5374.335140-145","doi-asserted-by":"crossref","unstructured":"Yang S, Zhang J, Chen L (2020) The cells involved in the pathological process of diabetic retinopathy. Biomed Pharmacother 132:110818.","DOI":"10.1016\/j.biopha.2020.110818"},{"key":"key-10.4103\/1673-5374.335140-146","doi-asserted-by":"crossref","unstructured":"Yang X, Pan X, Zhao X, Luo J, Xu M, Bai D, Hu Y, Liu X, Yu Q, Gao D (2019a) Autophagy and Age-Related Eye Diseases. Biomed Res Int 2019:5763658.","DOI":"10.1155\/2019\/5763658"},{"key":"key-10.4103\/1673-5374.335140-147","doi-asserted-by":"crossref","unstructured":"Yang Y, Gao H, Zhou H, Liu Q, Qi Z, Zhang Y, Zhang J (2019b) The role of mitochondria-derived peptides in cardiovascular disease: Recent updates. Biomed Pharmacother 117:109075.","DOI":"10.1016\/j.biopha.2019.109075"},{"key":"key-10.4103\/1673-5374.335140-148","doi-asserted-by":"crossref","unstructured":"Yi L, Swensen AC, Qian WJ (2018) Serum biomarkers for diagnosis and prediction of type 1 diabetes. Transl Res 201:13-25.","DOI":"10.1016\/j.trsl.2018.07.009"},{"key":"key-10.4103\/1673-5374.335140-149","doi-asserted-by":"crossref","unstructured":"Yuan L, Neufeld AH (2001) Activated microglia in the human glaucomatous optic nerve head. J Neurosci Res 64:523-532.","DOI":"10.1002\/jnr.1104"},{"key":"key-10.4103\/1673-5374.335140-150","doi-asserted-by":"crossref","unstructured":"Zantut PRA, Veras MM, Yariwake VY, Takahashi WY, Saldiva PH, Young LH, Damico FM, Fajersztajn L (2020) Effects of cannabis and its components on the retina: a systematic review. Cutan Ocul Toxicol 39:1-9.","DOI":"10.1080\/15569527.2019.1685534"},{"key":"key-10.4103\/1673-5374.335140-151","doi-asserted-by":"crossref","unstructured":"Zhang L, Bell BA, Yu M, Chan CC, Peachey NS, Fung J, Zhang X, Caspi RR, Lin F (2016) Complement anaphylatoxin receptors C3aR and C5aR are required in the pathogenesis of experimental autoimmune uveitis. J Leukoc Biol 99:447-454.","DOI":"10.1189\/jlb.3A0415-157R"},{"key":"key-10.4103\/1673-5374.335140-152","doi-asserted-by":"crossref","unstructured":"Zhu Y, Tchkonia T, Pirtskhalava T, Gower AC, Ding H, Giorgadze N, Palmer AK, Ikeno Y, Hubbard GB, Lenburg M, O\u2019Hara SP, LaRusso NF, Miller JD, Roos CM, Verzosa GC, LeBrasseur NK, Wren JD, Farr JN, Khosla S, Stout MB, et al. (2015) The Achilles\u2019 heel of senescent cells: from transcriptome to senolytic drugs. Aging Cell 14:644-658.","DOI":"10.1111\/acel.12344"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:27:30Z","timestamp":1787164050000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.335140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022]]},"references-count":152,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022]]}},"alternative-id":["335140"],"URL":"https:\/\/doi.org\/10.4103\/1673-5374.335140","relation":{},"ISSN":["1673-5374"],"issn-type":[{"value":"1673-5374","type":"print"}],"subject":[],"published":{"date-parts":[[2022]]}}}